Restructuring and other impairment charges (Tables)

12 Months Ended

Dec. 31, 2017

Restructuring and Related Activities [Abstract]

Restructuring and Other Impairment Charges

The restructuring and impairment charges recognized for the years ended December 31, 2017, 2016, and 2015 consisted of the following:

	2017
	Termination benefits		Facility closure and other exit costs			Contract termination costs		Total
	(Dollars in thousands)
2017 Vascular Solutions integration program	$	5,377	$	118		$	—	$	5,495
2017 EMEA restructuring program	4,921		280			—		5,201
Other 2016 restructuring programs	589		77			212		878
2016 Manufacturing footprint realignment plan	1,314		420			363		2,097
2014 Manufacturing footprint realignment plan	687		68			—		755
Other restructuring programs (1)	428		(160		)	96		364
Total restructuring charges	$	13,316	$	803		$	671	$	14,790

(1) Includes activity related to the 2017 Pyng Integration program and programs initiated in prior years that have been completed. The Company committed to the 2017 Pyng Integration program, which relates to the integration of Pyng Medical Corp. ("Pyng") into the Company, during the second quarter 2017, following the Company's acquisition of Pyng in April 2017.

	2016
	Termination benefits			Facility closure and other exit costs		Contract termination costs		Total
	(Dollars in thousands)
Other 2016 restructuring programs	$	2,531		$	12	$	671	$	3,214
2016 Manufacturing footprint realignment plan	11,176			468		866		12,510
2014 Manufacturing footprint realignment plan	81			38		—		119
Other restructuring programs(1)	(558		)	398		188		28
Total restructuring charges	$	13,230		$	916	$	1,725	$	15,871
Impairment charges	—			43,356		—		43,356
Total restructuring and impairment charges	$	13,230		$	44,272	$	1,725	$	59,227

(1) Includes activity primarily related to programs initiated in 2015 that were associated with the reorganization of certain businesses and shared service center functions as well as the consolidation of certain facilities in North America. These programs have been completed.

	2015
	Termination benefits			Facility closure and other exit costs		Contract termination costs			Total
	(Dollars in thousands)
2015 Restructuring programs	$	5,009		$	295	$	1,000		$	6,304
2014 Manufacturing footprint realignment plan	1,007			289		389			1,685
Other restructuring programs (1)	(194		)	37		(13		)	(170		)
Total restructuring charges	$	5,822		$	621	$	1,376		$	7,819

(1) Includes activity related to programs initiated, and substantially completed, in prior years.

Restructuring charges by reportable operating segment for the years ended December 31, 2017, 2016, and 2015 are set forth in the following table:

	2017		2016		2015
	(Dollars in thousands)
Vascular North America	$	2,595	$	5,843	$	3,049
Interventional North America	4,908		459		1,894
Anesthesia North America	1,262		1,839		384
Surgical North America	—		151		397
EMEA	5,722		4,423		4
Asia	—		—		313
OEM	—		795		61
All other	303		2,361		1,717
Total restructuring charges	$	14,790	$	15,871	$	7,819

Summary of Current Cost Estimates by Major Type of Cost

The following table provides a summary of the Company’s cost estimates by major type of expense associated with the 2014 Manufacturing Footprint Realignment Plan, which reflect the revised estimates:

Type of expense	Total estimated amount expected to be incurred
Termination benefits	$11 million to $12 million
Other exit costs (1)	$1 million to $2 million
Restructuring charges	$12 million to $14 million
Restructuring related charges (2)	$34 million to $37 million
	$46 million to $51 million

(1) Includes contract termination costs as well as facility closure and other exit costs (employee relocation costs, equipment relocation costs and outplacement).

(2) Consists of accelerated depreciation and other costs directly related to the plan, primarily as a result of the transfer of manufacturing operations to new locations.

Type of expense	Total estimated amount expected to be incurred
Termination benefits	$14 million to $15 million
Other exit costs (1)	$2 million to $3 million
Restructuring charges	$16 million to $18 million
Restructuring related charges (2)	$18 million to $26 million
	$34 million to $44 million

(1) Includes contract termination costs as well as facility closure and other exit costs (employee relocation costs, equipment relocation costs and outplacement).

(2) Consists of accelerated depreciation and other costs directly related to the plan, primarily as a result of the transfer of manufacturing operations to new locations.

Schedule of Restructuring Reserve

The following table summarizes the activity related to the 2016 Manufacturing Footprint Realignment Plan restructuring reserve:

	Termination benefits			Facility closure and other exit costs			Contract termination costs			Total
	(Dollars in thousands)
Balance at December 31, 2015	$	—		$	—		$	—		$	—
Subsequent accruals	11,176			468			866			12,510
Cash payments	(3,220		)	(469		)	(95		)	(3,784		)
Foreign currency translation	179			1			(11		)	169
Balance at December 31, 2016	8,135			—			760			8,895
Subsequent accruals	1,314			420			363			2,097
Cash payments	(2,096		)	(420		)	(798		)	(3,314		)
Foreign currency translation	(57		)	—			44			(13		)
Balance at December 31, 2017	$	7,296		$	—		$	369		$	7,665

The following table summarizes the activity related to the 2014 Manufacturing Footprint Realignment Plan restructuring reserve:

	Termination benefits			Facility closure and other exit costs			Total
	(Dollars in thousands)
Balance at December 31, 2015	$	7,447		$	—		$	7,447
Subsequent accruals	81			38			119
Cash payments	(2,158		)	(38		)	(2,196		)
Balance at December 31, 2016	5,370			—			5,370
Subsequent accruals	687			68			755
Cash payments	(2,131		)	(68		)	(2,199		)
Balance at December 31, 2017	$	3,926		$	—		$	3,926